サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1792821

プランティボディの世界市場

Plantibodies

出版日
ページ情報
英文 486 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
プランティボディの世界市場
出版日: 2025年08月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 486 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プランティボディの世界市場は2030年までに7,950万米ドルに達する見込み

2024年に5,320万米ドルと推定されるプランティボディの世界市場は、2024年から2030年にかけてCAGR 6.9%で成長し、2030年には7,950万米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるタバコは、CAGR 8.8％を記録し、分析期間終了時には2,430万米ドルに達すると予想されます。豆類セグメントの成長率は、分析期間でCAGR 4.6％と推定されます。

米国市場は1,450万米ドルと推定される一方、中国はCAGR 11.2％で成長すると予測される

米国のプランティボディ市場は、2024年には1,450万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 11.2%で推移し、2030年には予測市場規模1,690万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.8％と予測されています。欧州では、ドイツがCAGR 4.6%で成長すると予測されています。

世界のプランティボディ市場- 主要動向と促進要因まとめ

プランティボディとは何か、なぜバイオ医薬品の関心を集めているのか？

プランティボディは、分子農法により遺伝子操作された植物で生産される抗体です。哺乳類由来のモノクローナル抗体と同様の機能を持つが、タバコ、トウモロコシ、イネ、オオムギなどの植物発現系を用いて合成されます。これらの植物由来抗体は、特にワクチン、治療薬、診断薬において、従来のバイオ医薬品製造に代わるルートを提供します。

このコンセプトは、生産コストの低減、ヒト病原体による汚染リスクの低減、スケーラブルな農業ベースの製造など、いくつかの利点を提供します。プランティボディは、感染症、がん、自己免疫疾患の治療や診断キットの成分として研究されています。その関連性は、特に世界の健康上の緊急事態において、迅速かつ柔軟な生産プラットフォームへの需要が高まるにつれて高まっています。

植物抗体生産を支える技術はどのように進化しているのか？

植物抗体生産には、アグロバクテリウムを介した形質転換やウイルスベクターのような技術を用いて、抗体コード遺伝子を植物細胞に挿入することが含まれます。そして、これらのトランスジェニック植物は、その葉や種子で目的の抗体を産生します。収穫された材料は、機能的な抗体を抽出するために処理され、精製されます。植物発現ベクター、グリコシル化制御、下流の精製の進歩により、収量とヒト抗体との生物学的同等性が向上しました。

植物ウイルスベクターを用いた一過性発現系における最近の技術革新は、迅速な生産サイクルと新たな疾患ターゲットへの適応性を可能にしています。植物細胞培養、封じ込め農法、分子設計の改善により、バッチ間で一貫した性能がさらに可能になりました。糖鎖工学技術は、有効性の向上と免疫原性の低減のために、植物由来の抗体をヒト化するために使用されています。

アプリケーションはどこで拡大し、誰がプランティボディを使っているのか？

研究や初期段階の臨床研究では、エボラ出血熱、ジカ熱、COVID-19、特定のがんなどの症状に対してプランティボディが評価されています。いくつかのバイオテクノロジー会社や公衆衛生機関が、ニコチアナ・ベントハミアナやその他のモデル植物を用いた試験やパイロット生産プログラムを開始しています。プランティボディは、獣医学、食品安全診断、環境バイオセンシングの分野でも研究されています。

製薬会社は、大規模でコスト重視の抗体生産に植物ベースのシステムを検討するようになってきています。バイオシミラーや新規治療薬が注目されるようになるにつれ、柔軟でスケーラブルなバイオセーフ製造への需要が高まっています。診断キットの開発者は、特に低リソース環境での使用に向けて、迅速で安定した輸送可能な検査ソリューションを開発するためにプランティボディを使用しています。

プランティボディ市場の成長は、いくつかの要因によって牽引されています。

プランティボディ市場の成長は、費用対効果の高いバイオ治療薬へのニーズの高まり、植物発現系の遺伝子工学の改良、新興疾患に対応した迅速な抗体産生への需要の高まりによってもたらされます。一過性発現技術の拡大、下流処理の改善、植物ベースのバイオセーフティプロファイルの台頭が採用を後押ししています。

世界ヘルス診断への応用、パンデミック対策としての分子農法への関心、バイオテクノロジー企業と農業研究者との提携が開発を加速しています。ポイント・オブ・ケア検査、動物用治療薬、受動的免疫戦略での使用も市場の可能性に寄与しています。規制の枠組みが植物由来の生物製剤をサポートするように進化するにつれて、プランティボディは製薬パイプラインと世界・ヘルス戦略においてより大きな受容を得る立場にあります。

セグメント

遺伝子組換え作物（タバコ、豆類、穀類、種子・塊茎、果物・野菜、その他の遺伝子組換え作物）、技術（従来法技術、組織培養技術、育種・交配技術、遺伝子組換え種子技術、その他の技術）、用途（自己免疫疾患用途、がん用途、感染症用途、予防接種用途、歯科用途、その他用途）、最終用途（バイオ・製薬企業、学術・研究機関、その他最終用途）

調査対象企業の例

  • Agrisera AB
  • Biolex Therapeutics（Synthon）
  • Fraunhofer IME
  • Greenovation Biotech GmbH
  • IBIO, Inc.
  • Icon Genetics（Nomad Bioscience）
  • Kentucky BioProcessing Inc.
  • Leaf Expression Systems
  • Mapp Biopharmaceutical, Inc.
  • Medicago Inc.
  • Morphosys AG
  • Planet Biotechnology Inc.
  • PlantForm Corporation
  • PlantiBodies（startup）
  • Protalix BioTherapeutics Inc.
  • Qualcomm of plantibodies **Ventria Bioscience Inc.
  • Pfizer Inc.
  • ZEA Biosciences
  • Biocon Limited
  • iVitria/Ventria Affiliates**

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37749

Global Plantibodies Market to Reach US$79.5 Million by 2030

The global market for Plantibodies estimated at US$53.2 Million in the year 2024, is expected to reach US$79.5 Million by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Tobacco, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$24.3 Million by the end of the analysis period. Growth in the Legumes segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$14.5 Million While China is Forecast to Grow at 11.2% CAGR

The Plantibodies market in the U.S. is estimated at US$14.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$16.9 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Plantibodies Market - Key Trends & Drivers Summarized

What Are Plantibodies and Why Are They Attracting Biopharmaceutical Interest?

Plantibodies are antibodies produced in genetically engineered plants through molecular farming. They function similarly to mammalian-derived monoclonal antibodies but are synthesized using plant expression systems such as tobacco, corn, rice, or barley. These plant-based antibodies offer an alternative route to traditional biopharmaceutical manufacturing, particularly for vaccines, therapeutics, and diagnostic agents.

The concept offers several advantages including lower production costs, reduced risk of contamination with human pathogens, and scalable agriculture-based manufacturing. Plantibodies are being explored for the treatment of infectious diseases, cancer, autoimmune conditions, and as components in diagnostic kits. Their relevance grew with increasing demand for rapid and flexible production platforms, especially during global health emergencies.

How Is the Technology Behind Plantibody Production Evolving?

Plantibody production involves inserting antibody-encoding genes into plant cells using techniques like Agrobacterium-mediated transformation or viral vectors. These transgenic plants then produce the desired antibodies in their leaves or seeds. The harvested material is processed and purified to extract functional antibodies. Advances in plant expression vectors, glycosylation control, and downstream purification have improved yield and biological equivalence to human antibodies.

Recent innovations in transient expression systems using plant viral vectors allow rapid production cycles and adaptability to emerging disease targets. Improvements in plant cell culture, containment farming, and molecular design have further enabled consistent performance across batches. Glycoengineering techniques are being used to humanize plant-derived antibodies for improved efficacy and reduced immunogenicity.

Where Are Applications Expanding and Who Is Using Plantibodies?

Research and early-stage clinical studies are evaluating plantibodies for conditions such as Ebola, Zika, COVID-19, and certain cancers. Several biotechnology companies and public health institutions have initiated trials and pilot production programs using Nicotiana benthamiana and other model plants. Plantibodies are also being explored in veterinary medicine, food safety diagnostics, and environmental biosensing.

Pharmaceutical producers are increasingly considering plant-based systems for large-scale, cost-sensitive antibody production. As biosimilars and novel therapeutics become more prominent, the demand for flexible, scalable, and biosafe manufacturing alternatives is growing. Diagnostic kit developers are using plantibodies to create rapid, stable, and transportable testing solutions, particularly for use in low-resource settings.

Growth in the Plantibodies market is driven by several factors…

Growth in the plantibodies market is driven by increasing need for cost-effective biotherapeutics, improved genetic engineering of plant expression systems, and growing demand for rapid antibody production in response to emerging diseases. Expansion of transient expression techniques, improved downstream processing, and the rise of plant-based biosafety profiles are supporting adoption.

Application in global health diagnostics, interest in molecular farming for pandemic preparedness, and partnerships between biotech firms and agriculture researchers are accelerating development. Use in point-of-care testing, veterinary therapeutics, and passive immunization strategies also contributes to market potential. As regulatory frameworks evolve to support plant-based biologics, plantibodies are positioned to gain greater acceptance in pharmaceutical pipelines and global health strategies.

SCOPE OF STUDY:

The report analyzes the Plantibodies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Other Transgenic Crops); Technique (Conventional Method Technique, Tissue Culture Technique, Breeding & Sexual Crossing Technique, Transgenic Seeds Technique, Other Techniques); Application (Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

  • Agrisera AB
  • Biolex Therapeutics (Synthon)
  • Fraunhofer IME
  • Greenovation Biotech GmbH
  • IBIO, Inc.
  • Icon Genetics (Nomad Bioscience)
  • Kentucky BioProcessing Inc.
  • Leaf Expression Systems
  • Mapp Biopharmaceutical, Inc.
  • Medicago Inc.
  • Morphosys AG
  • Planet Biotechnology Inc.
  • PlantForm Corporation
  • PlantiBodies (startup)
  • Protalix BioTherapeutics Inc.
  • Qualcomm of plantibodies?** Ventria Bioscience Inc.
  • Pfizer Inc.
  • ZEA Biosciences
  • Biocon Limited
  • iVitria / Ventria Affiliates**

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Plantibodies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Cost-Effective Biologics Propels Interest in Plantibody Production Platforms
    • Advancements in Plant Molecular Farming Strengthen the Business Case for Plant-Derived Therapeutic Antibodies
    • Increasing Global Emphasis on Pandemic Preparedness Throws the Spotlight on Rapid-Scale Antibody Manufacturing via Plants
    • Lower Risk of Human Pathogen Contamination Supports Regulatory Momentum for Plant-Based Biopharmaceuticals
    • Growth in Monoclonal Antibody Therapies Expands the Addressable Market for Alternative Expression Systems
    • Technological Innovations in Transient Expression Systems Drive Rapid and Scalable Plantibody Yields
    • Shift Toward Decentralized and Low-Cost Biomanufacturing Fuels Adoption in Emerging and Low-Resource Regions
    • Use of Plantibodies in Veterinary and Agricultural Applications Opens Non-Human Health Market Opportunities
    • Global Expansion of Biosimilar and Biobetter Markets Creates Long-Term Demand for Low-Cost Antibody Production Systems
    • Inclusion of Plantibodies in Orphan Drug and Rare Disease Pipelines Enhances Market Differentiation
    • Challenges in Downstream Processing and Product Consistency Throw the Spotlight on Bioprocess Optimization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Plantibodies Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Plantibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tobacco by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Tobacco by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Legumes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Legumes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cereals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cereals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Seeds & Tubers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Seeds & Tubers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Fruits & Vegetables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Fruits & Vegetables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Transgenic Seeds Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Transgenic Seeds Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Conventional Method Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Conventional Method Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Tissue Culture Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Tissue Culture Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Breeding & Sexual Crossing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Breeding & Sexual Crossing Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Immunization Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Immunization Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Dentistry Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Dentistry Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 65: USA Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: USA 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 74: USA Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: USA Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: USA 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 86: Canada Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Canada Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Canada 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Japan 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 101: China Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: China 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Plantibodies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 128: France Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: France 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: France 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Germany 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Germany 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Germany 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Italy 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Italy 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Italy 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 164: UK Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 167: UK Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: UK 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: UK 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: UK 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 179: Spain Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Spain Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Spain 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Spain 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Spain 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 191: Russia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Russia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: Russia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 194: Russia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Russia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Russia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Russia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Europe Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Europe 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Europe Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Europe 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Europe Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Europe 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Plantibodies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 220: Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 223: Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 226: Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 230: Australia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Australia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 232: Australia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 233: Australia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Australia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 235: Australia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 236: Australia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Australia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 238: Australia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 239: India Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 242: India Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: India Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 244: India 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 245: India Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: India Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 247: India 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 248: India Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: India Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 250: India 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 254: South Korea Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: South Korea Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 256: South Korea 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 257: South Korea Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: South Korea Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 259: South Korea 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 260: South Korea Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: South Korea Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 262: South Korea 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Asia-Pacific Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Asia-Pacific Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Rest of Asia-Pacific Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Plantibodies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 281: Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 283: Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 284: Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 286: Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 287: Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 289: Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 293: Argentina Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Argentina Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 295: Argentina 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 296: Argentina Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Argentina Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 298: Argentina 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 299: Argentina Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Argentina Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 301: Argentina 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 305: Brazil Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Brazil Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 307: Brazil 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 308: Brazil Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Brazil Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 310: Brazil 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 311: Brazil Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Brazil Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 313: Brazil 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 317: Mexico Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Mexico Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 319: Mexico 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 320: Mexico Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Mexico Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 322: Mexico 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 323: Mexico Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Mexico Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 325: Mexico 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Rest of Latin America Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 331: Rest of Latin America 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Rest of Latin America Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 334: Rest of Latin America 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Rest of Latin America Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 337: Rest of Latin America 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Plantibodies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Plantibodies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 344: Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 346: Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 347: Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 349: Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 350: Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 352: Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 356: Iran Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Iran Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 358: Iran 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 359: Iran Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Iran Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 361: Iran 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 362: Iran Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Iran Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 364: Iran 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 368: Israel Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Israel Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 370: Israel 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 371: Israel Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Israel Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 373: Israel 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 374: Israel Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Israel Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 376: Israel 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Saudi Arabia Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 382: Saudi Arabia 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Saudi Arabia Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 385: Saudi Arabia 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Saudi Arabia Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 388: Saudi Arabia 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 392: UAE Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: UAE Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 394: UAE 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 395: UAE Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 396: UAE Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 397: UAE 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 398: UAE Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 399: UAE Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 400: UAE 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Rest of Middle East Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 406: Rest of Middle East 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Rest of Middle East Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 409: Rest of Middle East 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Rest of Middle East Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 412: Rest of Middle East 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Plantibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Plantibodies by Transgenic Crop - Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Plantibodies by Transgenic Crop - Percentage Breakdown of Value Sales for Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables and Other Transgenic Crops for the Years 2014, 2025 & 2030
    • TABLE 416: Africa Recent Past, Current & Future Analysis for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Africa Historic Review for Plantibodies by Technique - Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 418: Africa 16-Year Perspective for Plantibodies by Technique - Percentage Breakdown of Value Sales for Transgenic Seeds Technique, Other Techniques, Conventional Method Technique, Tissue Culture Technique and Breeding & Sexual Crossing Technique for the Years 2014, 2025 & 2030
    • TABLE 419: Africa Recent Past, Current & Future Analysis for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Africa Historic Review for Plantibodies by Application - Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 421: Africa 16-Year Perspective for Plantibodies by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Cancer Application, Infectious Diseases Application, Immunization Application, Dentistry Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 422: Africa Recent Past, Current & Future Analysis for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Africa Historic Review for Plantibodies by End-Use - Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 424: Africa 16-Year Perspective for Plantibodies by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, Academic & Research Institutes End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION